Pyrazoline: A Promising Scaffold for the Inhibition of Monoamine Oxidase

Author(s): Bijo Mathew, Jerad Suresh, Sockalingam Anbazhagan, Githa Elizabeth Mathew

Journal Name: Central Nervous System Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Central Nervous System Agents

Volume 13 , Issue 3 , 2013


Become EABM
Become Reviewer
Call for Editor

Abstract:

In the five membered nitrogen containing heterocyclic family, pyrazoline could be recognized as a promising scaffold for the inhibition of Monoamine oxidase. Substitution at 1, 3 and 5-position of the pyrazoline nucleus displayed a significant activity towards MAO in the past 15 years. Our study identified the detailed structure activity relationship, the structural requirement for enzyme interaction and the effect of chirality on the pyrazoline nucleus towards MAO-A and MAO-B. We propose that the selectivity of pyrazoline nucleus towards MAO isoenzyme depends up on the bulkiness of the ring in the 1 and 3 position of the scaffold. The current review revealed that the derivatives of pyrazolines have proven to be versatile pharmacophores for the inhibition of MAO on the basis of existing literatures between (1998-2013).

Keywords: Anti-depressant, MAO-A, MAO-B, chirality, molecular docking.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 3
Year: 2013
Published on: 29 January, 2014
Page: [195 - 206]
Pages: 12
DOI: 10.2174/1871524914666140129122632
Price: $65

Article Metrics

PDF: 49